ArticleJournal of pharmacy & bioallied sciences2026
Assessment of Obstructive Sleep Apnea (OSA) Risk in Western Region of Gujarat - A Cross-Sectional Study.
Article in Journal of pharmacy & bioallied sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Obstructive sleep apnea (OSA) remains underdiagnosed in India because polysomnography (PSG) is costly and not widely available. The STOP-Bang questionnaire offers a simple and reliable method to screen high-risk individuals in outpatient settings. Methods: A cross-sectional study was conducted among 368 adults attending a tertiary-care hospital in western Gujarat. All participants completed the STOP-Bang questionnaire. A score ≥5 was classified as high-risk for OSA. Data were analyzed using SPSS v24. Results: Out of 368 participants, 82 (22.8%) were in the high-risk group (STOP-Bang ≥5), while 277 (77.2%) were low-moderate risk. High-risk scores were significantly more common in males, participants aged >50 years, and those with higher body mass index (BMI). Conclusion: About one-fourth of adults screened in this OPD cohort were at high risk for OSA. STOP-Bang proved practical, low-cost, and suitable for early triage in regions where access to PSG is limited.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.